Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin-Reference-Cited by-同舟云学术

Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin

Published:2020-05-26 Issue:6 Volume:13 Page:1236-1243
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Lehtisalo Minna¹²,Keskitalo Jenni E.¹²,Tornio Aleksi¹²,Lapatto‐Reiniluoto Outi¹²,Deng Feng¹²,Jaatinen Taina³,Viinamäki Jenni¹²,Neuvonen Mikko¹²,Backman Janne T.¹²,Niemi Mikko¹²

Affiliation:

1. Department of Clinical Pharmacology University of Helsinki and Helsinki University Hospital Helsinki Finland

2. Individualized Drug Therapy Research Program University of Helsinki Helsinki Finland

3. The Finnish Red Cross Blood Service Helsinki Finland

Funder

Sigrid Juséliuksen Säätiö

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12809

Reference41 articles.

1. Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men

2. Alcohol intake and risk of incident gout in men: a prospective study

3. Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in Men

4. Gout. Epidemiology of gout

5. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of Urate Homeostasis by Membrane Transporters;Gout, Urate, and Crystal Deposition Disease;2024-06-19

2. Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling;Clinical Pharmacology & Therapeutics;2024-06-11

3. Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment;Pharmacology & Therapeutics;2024-05

4. Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1;Journal of Pharmacology and Experimental Therapeutics;2024-04-26

5. Clinical Analysis and <i>in Vitro</i> Correlation of BCRP-Mediated Drug–Drug Interaction in the Gastrointestinal Tract;Biological and Pharmaceutical Bulletin;2024-04-01